- Anticoagulation therapies help prevent blood clots, reducing the risk of stroke, heart attacks, and venous thromboembolism. These therapies have become essential in managing cardiovascular and hematological disorders, especially among the elderly and high-risk patient groups.
- North America leads global adoption due to advanced healthcare infrastructure, clinical awareness, and accessibility to high-end therapies.
- The United States dominates the market owing to high healthcare spending, early adoption of new therapies, and the presence of leading pharmaceutical players.
- Canada is projected to witness the fastest growth due to expanding insurance coverage, government health initiatives, and national screening programs.
- Direct Oral Anticoagulants (DOACs) segment is expected to lead with a share of 54.1% driven clinical preference for simplified dosing regimens and safety in elderly populations.
